Google RankBrain

BonusBonanza.info
CoinOasis.info
MagicTreasure.info
ScatterSlots.info
FruityFrenzy.info
Classic777.info
MegaSpinCasino.info
LuckyLarrySlots.info
ZeusSlots.info
DragonSpins.info
MythicalFortune.info
UnderseaAdventure.info
SpaceVoyager.info
CandyLandCasino.info
GemtopiaSlots.info
AnimalKingdomSlots.info
SportsFanSlots.info
MusicManiaSlots.info
MovieMagicSlots.info
HolidayFunSlots.info
PlayForFunSlots.info
SmartSpinsCasino.info
GambleAwareSlots.info
ResponsiblyWinning.info
SetYourLimitsCasino.info
TakeABreakSlots.info
PlayWithinYourMeans.info
KnowYourOddsCasino.info
SeekHelpIfNeeded.info
FunNotAddiction.info
BalancedGaming.info
MindfulSpins.info
SelfControlCasino.info
HealthyHabitsSlots.info
CasualGamerSlots.info
PennySlotsPalace.info
VIPSlotsLounge.info
SocialSlotsClub.info
WomensSlotsNetwork.info
SeniorsSlotsHub.info
SlotsForFunLovers.info
NoRiskNoStressSlots.info
RelaxAndSpinCasino.info
ThrillSeekerSlots.info
AdventureAwaitsCasino.info
MysteryUnveiledSlots.info
FantasyRealmCasino.info
SciFiSlotsGalaxy.info
HistoricalSlotsEra.info
SportsFanCasino.info
MusicLoverSlots.info
MovieBuffSlots.info
FoodieSlotsDelight.info
ReelRush.info
SlotSupernova.info
JackpotGalaxy.info
BonusBonanza.info
CoinCarnival.info
VegasVoyage.info
MagicSpindom.info
WildWonderland.info
ScatterSkies.info
FruityFiesta.info
ClassicKingdom.info
MegaSpinMania.info
LuckyLarrysLounge.info
StarburstSpins.info
ZeussThunder.info
MythicalFortune.info
PharaohsPalace.info
UnderseaReels.info
SpaceSpins.info
CandyLandCoins.info
GemtopiaGroove.info
SportsFanFrenzy.info
HolidayFunSpins.info
JackpotJungle.info

Nucleic Acid Testing Market Trend, Outlook 2025

This testing (NAT) or nucleic acid amplification test (NAAT) is one of the advanced diagnostic test increasingly gaining traction over conventional culture methods, owing to high efficiency and accuracy. Furthermore, This testing has potential application in various life threating diseases including cancer, infectious disease, genetic and mitochondrial disorders, and also in development of personalized and precision medicine. NAT is an efficient diagnostic method, which significantly reduces the procedural time and consumption of reagents. Moreover, this testing is increasingly being used for screening blood donation samples to reduce the risk of transfusion transmitted infections (TTIs), thus aiding in growth of the nucleic acid testing market.Nucleic Acid Testing Market – DriverThese tests are extensively used for screening and diagnosis of various infectious diseases. Moreover, growing prevalence of infectious diseases and management of epidemics of new diseases has led to increasing demand for advanced diagnostic tests such as nucleic acid testing. For instance, according to the World Health Organization (WHO), in 2015, around 32,000 estimated deaths from tuberculosis and around 3, 23,000 new cases of TB were registered in the European region. Furthermore, according to the Centers for Disease Control and Prevention (CDC), around 5,251 deaths due to influenza infection were registered in 2015, in the U.S. According to the National Ambulatory Medical Care Survey: 2015 data findings, 16.8 million visits to physician offices for infectious and parasitic diseases were registered in the U.S. Nucleic acid testing (NAT) enables to examine various changes in gene sequence and copy number, and provides information regarding disease recurrence and possible condition of patient to likely respond to a particular treatment. Moreover, NAT can identify, which patient have undergone inherited mutations, which eventually helps to identify whether the patient is at increased risk of developing cancer or not. Increasing incidence of cancer in various geographical areas is a major driving factor for growing adoption of nucleic acid testing. For instance, according to the Cancer Atlas: 2017, there were an estimated 14.1 million new cancer cases in 2012. Moreover, India, China, and other East and Central Asian countries accounted for nearly half of world’s new cancer cases and deaths, in 2017. Furthermore, according to the same source, by 2025, there will be an estimated 19.3 million new cancer cases and 11.4 million cancer deaths, in less developed regions.Moreover, research funding by various government and private organizations for cancer treatment and increasing adoption of molecular and nucleic acid testing in cancer research programs, to detect molecular genetic changes in single or multiple sequence of DNA or mutations is expected to aid in growth of the nucleic acid testing market, in the near future. In 2016, National Cancer Institute (NCI) invested US$ 3.9 billion for cancer research activities, which accounts for 70.8% of overall NCI 2016 budget. Among which NCI invested around US$ 533 million on cancer detection and diagnostic research activities. Moreover, in 2016, NCI allocated 40.4% of its funds for Research Project Grants (RPGs). Furthermore, in 2017, NCI budget increased by US$ 454 million (8.7%) from previous year (2016) for research activities.Request for Customization @ https://www.coherentmarketinsights.com/ongoing-insight/toc/1644Market – RestraintThe inability or difficulty of nucleic acid testing in obtaining quantitative results from a large pool of clinical sample, difficulty of using NAT test for susceptibility testing, and higher cost of nucleic acid testing devices is expected to hamper growth of the nucleic acid testing market. According to the data published in Asian Journal of Transfusion Science, in February 2014, NAT is highly sensitive and advanced technique, however, it is associated with high cost and requires dedicated infrastructure facility, equipment, consumables, and technical expertise.Market – Regional AnalysisGeographically, global nucleic acid testing market is segmented into North America, Latin America, Europe, Middle East, Asia Pacific, and Africa. North America holds dominant position in nucleic acid testing market, followed by Europe. This is owing to increasing research and development studies by various government and pharmaceutical organizations in infectious disease and cancer diagnosis in North America. For instance, in January 2018, University of Glasgow-led project received US$ 1.85 million funding, which is a part of Global Challenges Research Fund (GCRF). This project will develop new tests for parasitic diseases and rapid testing in remote locations to help enable rapid diagnosis, and rapid treatment of infectious disease. Furthermore, high prevalence and awareness of cancer among people, in turn opting for early detection of cancer, is expected to aid in growth of the nucleic acid testing market in this region. For instance, according to American Cancer Society, data findings, North America registered higher incidence of cancer in children compared to any other region, in 2012. Moreover, North America accounted for 13.1% of total estimated cases of cancer, in 2012, globally, according to the same source.Asia Pacific is expected to witness fastest growth in the nucleic acid testing market over the forecast period. This is due to growing demand for efficient and quick diagnostic testing and increasing focus of major market players to expand their geographical reach in this region. For instance, in March 2013, Qiagen N.V. launched its careHPV test in China. careHPV is molecular diagnostic test designed to screen for high risk human papillomavirus (HPV) for low-resource settings such as areas lacking electricity, water or laboratories. Qiagen also gained the approval from China’s State Food and Drug Administration (SFDA) for careHPV in 2012.Market – Competitive AnalysisKey market players in nucleic acid testing market are Abbott Laboratories, Beckman Coulter, Inc., Becton, Dickinson and Company, BioMérieux SA, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., Grifols, S.A., Illumina, Inc., Novartis Ag, Qiagen N.V., Quest Diagnostics Incorporated, Siemens Ag, and Tecan Group Ltd., among others. Players in the market are focusing on inorganic growth strategies, in order to enhance its market share and remain competitive in the market. For instance, in January 2017, Grifols, S.A. acquired the NAT (Nucleic Acid Testing) donor screening unit from Hologic, Inc. for US$ 1,850 million. The acquisition enabled Grifols to strengthen its position in transfusion medicine through NAT technology.Market – TaxonomyBy Product Type
Test Kits

Polymerase Chain Reaction(PCR)

Ligase Chain Reaction(LCR)

Transcription-mediated Amplification (TMA)

Whole Genome Sequencing

Consumables
By Indication
Infectious Disease

Cancer

Forensic Testing

Personalized Medicine

Others

By End User
Hospitals & Clinics

Pathology Laboratories

Academic & Research Organization

By Geography:
North America

Latin America

Europe

Asia Pacific

Middle East

Africa

About Coherent Market Insights:Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.Contact Us:Mr. ShahCoherent Market Insights1001 4th Ave, #3200Seattle, WA 98154Tel: +1-206-701-6702Email: [email protected]

Value Trap

urbanshift.info
cybervista.info
insightwave.info
energygenius.info
mediashift.info
launchsynth.info
quantumvista.info
geniuslink.info
skypulse.info
healthforge.info
datahorizon.info
alphaflow.info
nexusgenius.info
techecho.info
ideahorizon.info
ecosynth.info
solarforge.info
sparkvista.info
cryptogenius.info
connectsynth.info
pixellink.info
urbanflow.info
cybershift.info
insightsphere.info
energypulse.info
mediazenith.info
geniusforge.info
skybloom.info
alphasync.info
nexuswave.info
techmingle.info
ideavista.info
ecoshift.info
sparksynth.info
logicshift.info
connectwave.info
insightgaze.info
energynest.info
launchloom.info
geniushive.info
skynetizen.info
ideaburst.info
nexussync.info
alphasphere.info
techtide.info
ecosavvy.info
cloudhorizon.info
solarbrite.info
visionarylink.info
sparkforge.info
globalecho.info
logicnest.info
energynook.info
mediasavvy.info
launchpod.info
quantumsync.info
urbanbloom.info
mindcircuit.info
skywardtech.info
healthzenith.info
datavista.info
cloudfusion.info
webmastery.info
creativewave.info
startupnest.info
startupwave.info
digitalnest.info
creativepulse.info
connectideas.info
ecozenith.info
launchzen.info
urbanpulse.info
databurst.info
cloudvista.info
insightnest.info
codesphere.info
energyshift.info
websynth.info
urbanecho.info
aerotech.info
sparkwave.info
codesavvy.info
logicsphere.info
solarzenith.info
technook.info
websavvy.info
quantumquest.info
urbansynth.info
insightsync.info
visionvista.info
techsynth.info
mindmingle.info
quantumwave.info
launchnest.info
ideamastery.info
mediaspark.info
connecthorizon.info